Press releases

Top winners will be awarded up to $50,000 of in-kind support to advance submitted concept

Boston Scientific will participate in the healthcare investor conference on March 7, 2017. A live webcast and replay will be available.

Boston Scientific will participate in the healthcare investor conference on Feb. 23, 2017. A live webcast and replay will be available.

"Boston Scientific delivered excellent financial results in 2016,” said CEO Mike Mahoney

Boston Scientific will participate in the healthcare investor conference on Feb. 15, 2017. A live webcast and replay will be available.

Boston Scientific will webcast its conference call with financial results and business highlights for Q4 ended Dec. 31, 2016. Learn how to tune in.

Boston Scientific will participate in the J.P. Morgan Healthcare Conference on January 10, 2017. A live webcast and replay will be available.

Acquisition will bring manufacturing assets and biologic tissue capabilities for use in Boston Scientific heart valve technologies.

Third consecutive “Best Places to Work for LGBT Equality” award

$75M transaction enhances manufacturing expertise in structural heart

Boston Scientific will participate in the healthcare conference on December 7, 2016. A live webcast and replay will be available.

Acquisition expands Boston Scientific endoscopy portfolio with a comprehensive array of gastrointestinal services and devices

Boston Scientific today announced that its Cork, Ireland manufacturing facility has received the 2016 Shingo Prize for Excellence in Manufacturing from the Shingo Institute, part of the Jon M....

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 28th Annual Piper Jaffray Healthcare Conference on November 29 in New York City. Jeff Mirviss, senior vice president &...

Boston Scientific (NYSE: BSX) today announced results from the first clinical trial evaluating the performance of the HeartLogic™ Heart Failure Diagnostic Service to predict impending heart...

Boston Scientific (NYSE: BSX) has acquired the gynecology and urology portfolio of Distal Access, LLC, a Salt Lake City based company that designs minimally invasive medical devices. The portfolio...

MARLBOROUGH, Mass., (Nov. 8, 2016) – Boston Scientific Corporation (NYSE: BSX) today announced the U.S. and European launch of the Dakota™ Nitinol Stone Retrieval Device with OpenSure™...

Boston Scientific Corporation (NYSE: BSX) today announced that its wholly owned merger subsidiary, Falcon Merger Corp., has extended its previously announced tender offer for all shares of...

Boston Scientific (NYSE: BSX) today announced the acquisition of the LumenR™ Tissue Retractor System from LumenR LLC, a privately held Newark, California based company. The LumenR Tissue...

Boston Scientific (NYSE: BSX) announced initial U.S. commercial performance results of the WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device today during a late-breaking clinical trial...

As part of the commitment to support health equity for all patients, Boston Scientific Corporation (NYSE: BSX) sponsored the PLATINUM Diversity study to evaluate the clinical outcomes of the...

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Stifel 2016 Healthcare Conference on November 15 in New York City. Dan Brennan, executive vice president & chief...

Boston Scientific Corporation (NYSE: BSX) generated sales of $2.105 billion during the third quarter ended September 30, 2016, compared to the company's guidance range for the quarter of $2.035 to...

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 25th Annual Credit Suisse Healthcare Conference on November 7, in Scottsdale, Arizona. Joe Fitzgerald, executive vice...

Boston Scientific (NYSE: BSX) today announced key data which will be presented at the 28th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular...